研究单位：[1]Chinese Academy of Sciences[2]Guangdong Provincial People's Hospital[3]Cancer Institute and Hospital, Chinese Academy of Medical Sciences[4]Beijing Friendship Hospital[5]Yunnan Cancer Hospital[6]Liaoning Tumor Hospital & Institute[7]First Hospital of China Medical University[8]Affiliated Hospital of Hebei University
研究目的：
This is a single-arm, multicentre study that aims to assess whether Radiomics combining multiparametric MRI and clinical data could be a good predictor of the responses to neoadjuvant chemotherapy in Breast Cancer.
